Factor XI Levels in Acute Ischemic Stroke

Completed

Conditions studied: Stroke

In brief

The purpose of this study is to evaluate the utility of measuring coagulation factor activities in the setting of acute ischemic stroke, as potential markers of inherited thrombotic risk. The investigators will determine if relationships exist between coagulation factors, including factor VIII, factor IX, and factor XI and clinical diagnosis, classification, and outcome. The investigators will determine if any significant elevations of these factor activities are independent thrombotic risk factors. Null Hypothesis: There is no statistical difference between coagulation factors, including factors VIII, IX, or XI activity levels in patients having acute ischemic stroke as compared to acute stroke mimics.

Key facts

Study ID

NCT00890812

Run by

University of Utah

People needed

450

Starts

2009-05-01

Expected to finish

2011-07-01

Last updated by the study team

2011-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Those clinically diagnosed with acute ischemic stroke
• 18 years of age or greater

You may not qualify if…

• Those without clinical diagnosis of acute ischemic stroke will be included in the control group.
• Patients with hemorrhagic strokes
• Inpatients who are evaluated through the Brain Attack protocol

Where it is running

• University of Utah Health Sciences Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.